Hepatology 51 , 121129 (2010)
[DOI] [PMC free article] [PubMed] [Google Scholar] 311.Ehudin M.A., Golla U., Trivedi D., Potlakayala S.D., Rudrabhatla S.V., Desai D., Dovat S., Claxton D., Sharma A
Samuel P, et al
Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CE (2015) Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
1 Introduction In 1817, the Swedish chemist Berzelius discovered a non-metallic element and named it selenium (Se)
Maintaining a balanced perspective on this option is crucial